Another critical aspect is the involvement of ATRX loss (negative status) in immune response, potentially increasing cytokine secretion, inflammatory infiltrates, and even tumor cell growth inhibition by immune cell effectors [27,7]. This evidence concerns the gene ATRX and neoplasm.